期刊文献+

蛋白质组学及其在前列腺癌研究中的应用 被引量:3

Proteomics and Its Application in the Research of Prostatic Carcinoma
下载PDF
导出
摘要 随着蛋白质组学技术的发展,越来越多的肿瘤标记物被发现,并逐渐应用于临床,这将为肿瘤的早期诊断和预后监测提供可靠的依据。现综述蛋白质组学的研究策略及其在前列腺癌研究中的应用。 With the development of the proteomics technology, more and more tumorous labeled substrates have been discovered and applied to clinical practice. This can provide the forepart diagnosis of tumor and prognosis monitoring with the reliable evidence. A summary is given of the study strategy of proteomics and its application in the prostatic carcinoma research.
出处 《中华男科学杂志》 CAS CSCD 2006年第4期358-361,共4页 National Journal of Andrology
关键词 蛋白质组学 前列腺癌 proteomics prostatic carcinoma
  • 相关文献

参考文献18

  • 1于正洪,陈龙邦.前列腺癌循环核酸的研究进展[J].中华男科学杂志,2004,10(7):543-546. 被引量:3
  • 2张灵,计国义,李晓萌,王伟华,高洪文,潘玉琢,王洪军,桑原正明,赵雪俭.fPSA/tPSA比值优化前列腺癌早期诊断作用的研究[J].中华男科学杂志,2004,10(8):582-585. 被引量:18
  • 3胡洁,朱有名,韩金祥.蛋白质芯片技术在蛋白质组研究领域的应用[J].国外医学(临床生物化学与检验学分册),2004,25(3):223-225. 被引量:7
  • 4Craven RA,Totty N,Harnden P,et al.Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis:evaluation of tissue preparation and sample limitations[J].Am J Pathol,2002,160(3):815-822.
  • 5Xiao Z,Adam BL,Cazares LH,et al.Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease[J].Cancer Res,2001,61(16):6029-6033.
  • 6Qu Y,Adam BL,Yasui Y,et al.Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients [J].Clin Chem,2002,48(10):1835-1843.
  • 7Adam BL,Qu Y,Davis JW,et al.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men[J].Cancer Res,2002,62(13):3609-3614.
  • 8Simone NL,Remaley AT,Charboneau L,et al.Sensitive immunoassay of tissue cell proteins procured by laser capture microdissection[J].Am J Pathol,2000,156(2):445-452.
  • 9Wellmann A,Wollscheid V,Lu H,et al.Analysis of microdissected prostate tissue with protein chip arrays-a way to new insights into carcinogenesis and to diagnostic tools [J].Int J Mol Med,2002,9(4):341-347.
  • 10Paweletz CP,Liotta LA,Petricoin EF 3rd.New technologies for biomarker analysis of prostate cancer progression:Laserl capture microdissection and tissue proteomics[J].Urology,2001,57(4A Suppl):160-163.

二级参考文献33

  • 1郭德荣,顾方六,周爱儒,俞莉章,丁义,钟华,蔡碧娟,郭应禄.p16基因在膀胱癌和尿生殖癌细胞株中的丢失[J].中华外科杂志,1996,34(11):643-644. 被引量:3
  • 2Uchida T,Fukawa A,Uchida M,et al.Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid.J Proteome Res,2002,1(6):495-499.
  • 3Wasinger VC,Cordwell SJ,Cerpa-Poljak A,et al.Progress with gene-product mapping of the Mollicutes:Mycoplasma genitalium.Electrophoresis,1995,16(7):1090-1094.
  • 4Poon TC,Yip TT,Chan AT,et al.Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.Clin Chem,2003,49(5):752-760.
  • 5Freedland SJ,Seligson DB,Liu AY,et al.Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.Prostate,2003,55(1):71-80.
  • 6Jazaeri AA,Lu K,Schmandt R,et al.Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.Mol Carcinog,2003,36(2):53-59.
  • 7Li J,Zhang Z,Rosenzweig J,et al.Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.Clin Chem,2002,48(8):1296-1304.
  • 8Caputo E,Camarca A,Moharram R,et al.Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.Biochemistry,2003,42(20):6169-6178.
  • 9Valafar F.Pattern recognition techniques in microarray data analysis:a survey.Ann N Y Acad Sci,2002,980:41-64.
  • 10Danesi R,de-Braud F,Fogli S,et al.Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.Pharmacol Rev,2003,55(1):57-103.

共引文献24

同被引文献17

  • 1张保国,姚乐申.奥曲肽对人类前列腺癌PC-3细胞凋亡及其对cyclinE蛋白表达的影响[J].南京医科大学学报(自然科学版),2005,25(12):928-930. 被引量:1
  • 2甘琳,李鸣.雄激素非依赖性前列腺癌发病机制的研究进展[J].中华外科杂志,2007,45(8):562-564. 被引量:4
  • 3Gernone A,Trabucco S,Pagliarulo V,et al.Different expression of somatostatin receptor subtypes in human prostate cancer[J].J Clin Oncol,2008,26(15S):16148.
  • 4Morichetti D,Mazzucchelli R,Santinelli A,et al.Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation[J].Int J Immunopathol Pharmacol,2010,23(2):511-522.
  • 5Xing Z,Zhou Z,Yu R,et al.XAF1expression and regulatory effects of somatostatin on XAF1in prostate cancer cells[J].J Exp Clin Cancer Res,2010,29:162.
  • 6Kouroumalis E,Skordilis P,Thermos K,et al.Treatment of hepatocellular carcinoma with octreotide:a randomised controlled study[J].Gut,1998,42(3):442-447.
  • 7Filosso PL,Ruffini E,Oliaro A,et al.Long-term survival of atypical bronchial carcinoids with liver metastases,treated with octreotide[J].Eur J Cardiothorac Surg,2002,21(5):913-917.
  • 8Foley R,Hollywood D,Lawler M.Molecular pathology of prostate cancer:the key to identifying new biomarkers of disease[J].Endocr Relat Cancer,2004,11(3):477-488.
  • 9Abrahamsson PA.Neuroendocrine cells in tumour growth of the prostate[J].Endocr Relat Cancer,1999,6(4):503-519.
  • 10Morichetti D,Mazzucchelli R,Santinelli A,et al.Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation[J].Int J Immunopathol Pharmacol,2010,23(2):511-522.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部